| ALIMP Stock | | | EUR 0.11 0.01 8.33% |
CEO
Mr. Ludovic Lastennet was Chief Executive Officer and Director of Implanet SA since January 22, 2013. He has over 19 years of experience in the field of Medicine capital goods, reconstructive orthopaedics, and dental implantology. He spent five years as Chief Executive Officer of a French subsidiary of KaVo Dental after six years spent as Director of Sales in France Germany, Austria Switzerland and countries of the East for Stryker Corporationrationration. He graduated from Institut Superieur de Gestion in 1988. since 2013.
| Tenure | 11 years |
| Phone | 33 5 57 99 55 55 |
| Web | https://www.implanet.com |
Implanet Management Efficiency
The company has return on total asset
(ROA) of
(0.1778) % which means that it has lost $0.1778 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(2.6622) %, meaning that it generated substantial loss on money invested by shareholders. Implanet's management efficiency ratios could be used to measure how well Implanet manages its routine affairs as well as how well it operates its assets and liabilities.
Implanet SA has accumulated 5.74
M in total debt with debt to equity ratio
(D/E) of 110.0, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Implanet SA has a current ratio of 1.25, suggesting that it
is in a questionable position to pay out its financial obligations in time and when they become due. Debt can assist Implanet until it has trouble settling it off, either with new capital or with free cash flow. So, Implanet's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Implanet SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Implanet to invest in growth at high rates of return. When we think about Implanet's use of debt, we should always consider it together with cash and equity.
Implanet S.A. provides various spine, knee, and arthroscopy orthopedic implants in France, the United States, Brazil, and internationally. Implanet S.A. was founded in 2006 and is based in Martillac, France. IMPLANET operates under Medical Devices classification in France and is traded on Paris Stock Exchange. It employs 45 people. Implanet SA (ALIMP) is traded on Euronext Paris in France and employs 39 people.
Management Performance
Implanet SA Leadership Team
Elected by the shareholders, the Implanet's board of directors comprises two types of representatives: Implanet inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Implanet. The board's role is to monitor Implanet's management team and ensure that shareholders' interests are well served. Implanet's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Implanet's outside directors are responsible for providing unbiased perspectives on the board's policies.
Implanet Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Implanet a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Implanet Stock Analysis
When running Implanet's price analysis, check to
measure Implanet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Implanet is operating at the current time. Most of Implanet's value examination focuses on studying past and present price action to
predict the probability of Implanet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Implanet's price. Additionally, you may evaluate how the addition of Implanet to your portfolios can decrease your overall portfolio volatility.